Short-Term Effects of Verapamil and Diltiazem in the Treatment of No Reflow Phenomenon: A Meta-Analysis of Randomized Controlled Trials

<div>Pooled risk ratio of verapamil/diltiazem versus control for TIMI flow after percutaneous coronary intervention. CI, confidence interval; M-H, Mantel-Haenszel; TIMI, thrombolysis in myocardial infarction.</div>

BioMed Research International

fig2

Figure 2

Figure 2: Short-Term Effects of Verapamil and Diltiazem in the Treatment of No Reflow Phenomenon: A Meta-Analysis of Randomized Controlled Trials 